2.1.2: Phosphodiesterase Type-3 inhibitors

Part of chapter 2 Cardiovascular System, section 2.1 Positive inotropic drugs


High-level prescribing trends for Phosphodiesterase Type-3 inhibitors (BNF section 2.1.2) across all GP practices in NHS England for the last five years. You can explore prescribing trends for this section by CCG, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.

Chemicals

Enoximone (0201020G0)
Milrinone lactate (0201020M0)